Evolving Markets, Innovative Solutions: The Rise of Specialty VBC
This new approach is helping payors and providers unlock new value from their VBC initiatives while offering more effective and condition-specific treatment for patients.
Chris Riopelle
Chris Riopelle is the co-founder and CEO of Strive Health. He leads the company in its efforts to improve the lives of underserved patients living with kidney disease – from chronic through end-stage. Strive Health supports 121,000 patients across 50 states with $3.8 billion in medical spend under management. Founded in 2018, Strive is home to 700 “Strivers” and has been recognized multiple times as a best place to work. Chris and Strive are proud to be partnered with blue chip investors such as NEA, CapitalG (Alphabet), CVS Health Ventures and Town Hall Ventures. In his role as CEO, Chris works to drive value for patients, providers and payors by transforming how kidney care is delivered in the U.S. Under his leadership, Strive Health’s innovative clinical model has improved care quality and reduced hospital admissions by nearly 50%, re-admissions by 30% and total cost of care by 20%.